Dr. Sheng-Hsiung, Hsu

Sheng-Hsiung is Chairmen of the Board of the Compal group, consisting of 17 companies in various industries including consumer electronics, optoelectronic, and biotechnology and medical care, with yearly revenues exceeding 33 billion USD in 2017. 7 companies within the group are listed in Taiwan and Thailand.

Sheng-Hsiung was a member of Senior Advisors to the President, National Policy Advisors to the President, head of Importers and Exporters Association of Taipei, Taiwan Electrical and Electronic Manufacturers’ Association, and Chinese National Federation of Industries. He received the National Quality Award and Distinguished Entrepreneur Award.

Dr. Jeff Chen

Dr. Chen possesses over 25 years of academic and industrial experiences in biomedical data analytics, new technology venture incubation and investment, corporate turnaround management, and strategic planning for institutional sustainability in US, Japan, and Taiwan.

Dr. Chen is currently the visiting professor at Kyoto University Institute for Advanced Study (KUIAS), Institute for Integrated Cell-Material Sciences (iCeMS), Japan, as well as the visiting professor at the BioMedical Translation Research Center of Academia Sinica, Taiwan; In addition, Dr. Chen is also holding two teaching positions (joint appointment) at the Department and Graduate Institute of Business Administration, College of Management, and the College of Medicine of National Taiwan University (NTU).

In the academic field, Dr. Chen serves as the Deputy Director of the iCeMS Taiwan Office at Kyoto University; he also serves as Deputy Director of the Center for Regenerative Medicine and Cellular Therapy (CRC), and the Adjunct Research Fellow in the System-on-Chip (SoC) Research Center at National Yang Ming Chiao Tung University (NYCU). In addition, in NTU, Dr. Chen served as the researcher at the Center for Artificial Intelligence and Advanced Robotics, as well as at the Center of Technology Policy and Industry Development.  He also serves as the President of NII Capital (an University Venture Capital of National Taiwan Normal University), which focus on business in the form of venture capital investments and assists the startups companies which derived from University to commercialize their technology.

►Investment and Operation Team

Anna Li

Graduated from the MBA program at National Taiwan Normal University, Anna holds a bachelor’s degree in Finance from National Central University.

Anna completed an internship at Taishin International Bank, served as the director and financial director in university student associations. She is experienced in finance and innovation through the combination of different technologies.

David Hong

Graduated from the MBA program at National Taiwan Normal University, David holds a bachelor’s degree in Economics from Soochow University.

Worked at National Theater & Concert Hall and NTNU Special Education Center. A sports enthusiast, knowledged in operation and financial management, he is interested in biotechnology and AI.